Iridian Asset Management »

Nektar Therapeutics shares owned by Iridian Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Iridian Asset Management from 13F filings

Historical chart of Iridian Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Iridian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Iridian Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $411k 9.7k 42.28

More positions owned by Iridian Asset Management

Acv Auctions Com Cl A (ACVA)
Herbalife Com Shs (HLF)
Hilton Grand Vacations (HGV)
Post Holdings Inc Common (POST)
Lithia Motors (LAD)
Precigen (PGEN)
Travel Leisure Ord (TNL)
Axsome Therapeutics (AXSM)
Bill Com Holdings Ord (BILL)
Rentokil Initial Sponsored Adr (RTO)
Anthem (ELV)
Element Solutions (ESI)
Ball Corporation (BALL)
Crown Holdings (CCK)
Digitalbridge Group Cl A New (DBRG)

View all positions for Iridian Asset Management

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics